Related references
Note: Only part of the references are listed.Adalimumab for the Treatment of Japanese Patients With Intestinal Behcet's Disease
Satoshi Tanida et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort
Stephan R. Vavricka et al.
INFLAMMATORY BOWEL DISEASES (2015)
Biologics for Extraintestinal Manifestations of IBD
Stephan R. Vavricka et al.
CURRENT DRUG TARGETS (2014)
Hepatobiliary Manifestations of Inflammatory Bowel Disease
Andres J. Yarur et al.
INFLAMMATORY BOWEL DISEASES (2014)
Anti-TNF-alpha therapy in patients with refractory uveitis due to Behcet's disease: a 1-year follow-up study of 124 patients
Vanesa Calvo-Rio et al.
RHEUMATOLOGY (2014)
Neurologic Complications in Patients with Inflammatory Bowel Disease: Increasing Relevance in the Era of Biologics
Siddharth Singh et al.
INFLAMMATORY BOWEL DISEASES (2013)
Periodontitis and Gingivitis in Inflammatory Bowel Disease: A Case-Control Study
Stephan R. Vavricka et al.
INFLAMMATORY BOWEL DISEASES (2013)
Extraintestinal manifestations and complications in IBD
Claudia Ott et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Treatment of Extraintestinal Manifestations in Inflammatory Bowel Disease
Peter L. Lakatos et al.
DIGESTION (2012)
Diagnosis and Therapeutic Management of Extra-Intestinal Manifestations of Inflammatory Bowel Disease
Guru Trikudanathan et al.
DRUGS (2012)
Frequency and Risk Factors for Extraintestinal Manifestations in the Swiss Inflammatory Bowel Disease Cohort
Stephan R. Vavricka et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
IBD and arthropathies: a practical approach to its diagnosis and management
Lianne K. P. M. Brakenhoff et al.
GUT (2011)
Leucocytoclastic Vasculitis in Severe Ulcerative Colitis
Donald Martin et al.
MILITARY MEDICINE (2011)
Hepatopancreatobiliary Manifestations and Complications Associated with Inflammatory Bowel Disease
Udayakumar Navaneethan et al.
INFLAMMATORY BOWEL DISEASES (2010)
Pathologic Features of Ulcerative Colitis in Patients With Primary Sclerosing Cholangitis A Case-control Study
Mee Joo et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2009)
Adalimumab Treatment for Peristomal Pyoderma Gangrenosum Associated with Crohn's Disease
Naim Alkhouri et al.
INFLAMMATORY BOWEL DISEASES (2009)
Rheumatic manifestations of inflammatory bowel disease
Tatiana Sofia Rodriguez-Reyna et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Combined therapeutic approach: Inflammatory bowel diseases and peripheral or axial arthritis
Fabiola Atzeni et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Successful use of adalimumab for treating fistulizing Crohn's disease with pyoderma gangrenosum: Two birds with one stone
Eva Zold et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Ulcerative colitis and Sweet's syndrome: A case report and review of the literature
Massud Ali et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY (2008)
Skin manifestations of inflammatory bowel disease
Shereen Timani et al.
CLINICS IN DERMATOLOGY (2008)
Extraintestinal manifestations of inflammatory bowel disease
S. Ardizzone et al.
DIGESTIVE AND LIVER DISEASE (2008)
Azathioprine-induced Sweet's Syndrome in Crohn's Disease
Xavier Treton et al.
INFLAMMATORY BOWEL DISEASES (2008)
Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases - A cohort study of 2402 patients
David Farhi et al.
MEDICINE (2008)
A case of fistulizing Crohn's disease and erythema nodosum managed with adalimumab
Alissa Quin et al.
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2008)
Adalimumab for treatment of pyoderma gangrenosum
R. G. Pomerantz et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Adalimumab in the therapy of uveitis in childhood
Sabine Biester et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2007)
Refractory chronic erythema nodosum successfully treated with adalimumab
N. Ortego-Centeno et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2007)
Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: A single center study
Jens J. W. Tischendorf et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Infliximab for the treatment of disseminated pyoderma gangrenosum associated with ulcerative colitis
Pascal Juillerat et al.
DERMATOLOGY (2007)
Treatment of chronic erythema nodosum with infliximab
T. H. Clayton et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2006)
Tumour necrosis factor α inhibitors in the treatment of childhood uveitis
R. K. Saurenmann et al.
RHEUMATOLOGY (2006)
Inflammatory bowel disease characteristics among African Americans, hispanics, and non-Hispanic Whites: Characterization of a large north American cohort
GC Nguyen et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis
J Zochling et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial
TN Brooklyn et al.
GUT (2006)
Anti-TNF therapies in the management of acute and chronic uveitis
Sarah Hale et al.
CYTOKINE (2006)
Primary sclerosing cholangitis, inflammatory a bowel disease, and colon cancer
Ulrika Broome et al.
SEMINARS IN LIVER DISEASE (2006)
Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease
K Takeuchi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Safety of celecoxib in patients with ulcerative colitis in remission: A randomized, placebo-controlled, pilot study
WJ Sandborn et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Retrospective case review of pediatric patients with uveitis treated with infliximab
RT Rajaraman et al.
OPHTHALMOLOGY (2006)
The gastrointestinal safety and effect on disease activity of etoricoxib, a selective Cox-2 inhibitor in inflammatory bowel diseases
Y El Miedany et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Extraintestinal manifestations in inflammatory bowel disease
Silvio Danese et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Erythema nodosum and pyoderma gangrenosum in 50 patients with Crohn's disease
HJ Freeman
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
The effect of infliximab on extraintestinal manifestations of Crohn's disease
I Kaufman et al.
RHEUMATOLOGY INTERNATIONAL (2005)
Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept
J Braun et al.
ARTHRITIS AND RHEUMATISM (2005)
Management of peristomal pyoderma gangrenosum
RP Kiran et al.
DISEASES OF THE COLON & RECTUM (2005)
Anti-TNF-α therapy for sight threatening uveitis
EW Lindstedt et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2005)
Primary sclerosing cholangitis
JA Talwalkar et al.
INFLAMMATORY BOWEL DISEASES (2005)
Important cutaneous manifestations of inflammatory bowel disease
LB Trost et al.
POSTGRADUATE MEDICAL JOURNAL (2005)
PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis
EV Loftus et al.
GUT (2005)
Infliximab as a treatment for recalcitrant pyoderma gangrenosum
M Singh et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2004)
Ocular manifestations of inflammatory bowel disease
R Mintz et al.
INFLAMMATORY BOWEL DISEASES (2004)
Tumor necrosis factor α blockade with infliximab for refractory uveltis and scleritis
CC Murphy et al.
OPHTHALMOLOGY (2004)
Treatment of pyoderma gangrenosum with Infliximab in Crohn's disease
MS Sapienza et al.
DIGESTIVE DISEASES AND SCIENCES (2004)
Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations
S Generini et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Autoimmune disorders and extraintestinal manifestations in first-degree familial and sporadic inflammatory bowel disease - A case-control study
E Ricart et al.
INFLAMMATORY BOWEL DISEASES (2004)
Dermatologic manifestations of Crohn disease in children: Response to infliximab
S Kugathasan et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2003)
Infliximab in the treatment of refractory posterior uveitis
A Joseph et al.
OPHTHALMOLOGY (2003)
An open-label trial of the selective cyclo-oxygenase-2 inhibitor, rofecoxib, in inflammatory bowel disease-associated peripheral arthritis and arthralgia
W Reinisch et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Infliximab for peristomal pyoderma gangrenosum
D Mimouni et al.
BRITISH JOURNAL OF DERMATOLOGY (2003)
Uveitis and erythema nodosum in inflammatory bowel disease: Clinical features and the role of HLA genes
TR Orchard et al.
GASTROENTEROLOGY (2002)
Pyoderma gangrenosum associated with Crohn disease:: effect of TNF-α blockade with infliximab
T Ljung et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2002)
Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis
RM Soetikno et al.
GASTROINTESTINAL ENDOSCOPY (2002)
Resolution of severe peristomal pyoderma gangrenosum with infliximab in a child with Crohn disease
LA Batres et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2002)
Corticosteroid-resistant pyoderma gangrenosum associated with Crohn's disease: Rapid cure with infliximab
F Grange et al.
DERMATOLOGY (2002)
Extraintestinal manifestations of inflammatory bowel disease
CYG Su et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2002)
Clinical use of Infliximab in Crohn's disease: the Edinburgh experience
IDR Arnott et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2001)
Effect of infliximab on sight-threatening panuveitis in Behcet's disease
PP Sfikakis et al.
LANCET (2001)
Muscoloskeletal manifestations in inflammatory bowel disease
G Fornaciari et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2001)
Crohn's disease arthritis treated with infliximab: An open trial in four patients
MH Ellman et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2001)
Crohn's disease associated with spondyloarthropathy:: effect of TNF-α blockade with infliximab on articular symptoms
F Van den Bosch et al.
LANCET (2000)
Clinical features and treatment of peristomal pyoderma grangrenosum
AP Hughes et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease
TR Orchard et al.
GASTROENTEROLOGY (2000)
A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions
ML Bennett et al.
MEDICINE (2000)
Share Paper
